Akums Drugs & Pharmaceuticals Ltd (AKUMS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039335, "name": "Akums Drugs", "stock_name": "Akums Drugs", "full_name": "Akums Drugs & Pharmaceuticals Ltd", "name_url": "stocks-analysis/akums-drugs", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "547.30", "chg": 3.6, "chgp": "0.66%", "dir": 1, "prev_price": "543.70", "mcapval": "8,515.00 Cr", "mcap": "Small Cap", "scripcode": "544222", "symbol": "AKUMS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE09XN01023", "curr_date": "Apr 30", "curr_time": "", "bse_nse_vol": "2.6 lacs", "exc_status": "Active", "traded_date": "Apr 30, 2026", "traded_date_str": "2026 04 30", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/akums-drugs-10039335-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Hold", "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-hold-3960761", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AkumsDrugsPharm_mojoScore_3960761.png", "date": "2026-04-24 10:10:03", "description": "Akums Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 10 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Akums Drugs Gains 5.90%: Technical Upgrades and Valuation Drive Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-gains-590-technical-upgrades-and-valuation-drive-momentum-3951839", "imagepath": "", "date": "2026-04-18 10:02:01", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Apr 13:</strong> Mojo Grade upgraded to Hold on improved technicals and valuation</p>\n <p><strong>Apr 15:</strong> Stock surges 3.99% amid bullish momentum confirmation</p>\n <p><strong>Apr 16:</strong> Continued gains with 0.92% rise supported by technical indicators</p>\n <p><strong>Apr 17:</strong> Slight profit-taking closes week at Rs.545.90 (-0.82%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.524.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</d..." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Upgraded to Hold on Technical and Valuation Improvements", "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-upgraded-to-hold-on-technical-and-valuation-improvements-3944210", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AkumsDrugsPharm_mojoScore_3944210.png", "date": "2026-04-13 08:26:12", "description": "Akums Drugs & Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold as of 10 April 2026, reflecting notable improvements in technical indicators and valuation metrics despite flat recent financial performance. The stock’s recent bullish momentum, attractive price-to-book ratio, and market-beating returns have contributed to this reassessment, signalling cautious optimism among investors." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-shows-bullish-momentum-amid-technical-upgrades-3944114", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AkumsDrugsPharm_technicaldot_3944114.png", "date": "2026-04-13 08:04:45", "description": "Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a series of positive technical indicator signals. This development comes alongside an upgrade in its MarketsMOJO grade from Sell to Hold, reflecting improved investor sentiment and technical strength in the small-cap pharmaceuticals sector." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Gains 4.60%: 3 Key Technical Signals Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-gains-460-3-key-technical-signals-driving-the-week-3942219", "imagepath": "", "date": "2026-04-11 10:00:56", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>6 Apr:</strong> Week opens at Rs.492.85</p>\n <p><strong>7 Apr:</strong> Technical momentum shifts to mildly bearish amid mixed market signals</p>\n <p><strong>9 Apr:</strong> Momentum shifts to sideways trend with a 3.19% intraday gain</p>\n <p><strong>10 Apr:</strong> Golden Cross formation signals potential bullish breakout; stock closes at Rs.515.50 (+4.84%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.492.85</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Cl..." }, { "title": "Golden Cross Forms in Akums Drugs & Pharmaceuticals Ltd — Mixed Technical Signals Demand Caution", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-forms-golden-cross-signalling-potential-bullish-breakout-3942045", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AkumsDrugsPharm_goldencross_3942045.png", "date": "2026-04-10 18:00:39", "description": "The 50-day moving average has crossed above the 200-day moving average for Akums Drugs & Pharmaceuticals Ltd, signalling a golden cross on 10 Apr 2026. Yet, the broader technical and fundamental picture presents a nuanced view that tempers the enthusiasm often associated with this crossover — is this a reliable signal or a misleading indicator for investors?" }, { "title": "Akums Drugs & Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/akums-drugs-pharmaceuticals-ltd-is-rated-sell-3939381", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AkumsDrugsPharm_mojoScore_3939381.png", "date": "2026-04-09 10:10:32", "description": "Akums Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-signals-3938890", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AkumsDrugsPharm_technicaldot_3938890.png", "date": "2026-04-09 08:07:07", "description": "Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent 3.19% gain in the stock price, the mixed signals from key technical indicators such as MACD, RSI, and moving averages suggest a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Akums Drugs & Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/akums-drugs-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-3935612", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AkumsDrugsPharm_technicaldot_3935612.png", "date": "2026-04-07 08:06:11", "description": "Akums Drugs & Pharmaceuticals Ltd has experienced a subtle but notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, the overall technical landscape presents a complex picture for investors, with mixed signals from key momentum and trend-following indicators." } ], "total": 186, "sid": "10039335", "stock_news_url": "https://www.marketsmojo.com/news/akums-drugs-pharmaceuticals-10039335" }, "announcements": "", "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Apr 13: Mojo Grade upgraded to Hold on improved technicals and valuation

Apr 15: Stock surges 3.99% amid bullish momentum confirmation

Apr 16: Continued gains with 0.92% rise supported by technical indicators

Apr 17: Slight profit-taking closes week at Rs.545.90 (-0.82%)

Week Open

Rs.524.45

Week CloseRead full news article

Akums Drugs & Pharmaceuticals Ltd Upgraded to Hold on Technical and Valuation Improvements

2026-04-13 08:26:12

Akums Drugs & Pharmaceuticals Ltd has seen its investment rating upgraded from Sell to Hold as of 10 April 2026, reflecting notable improvements in technical indicators and valuation metrics despite flat recent financial performance. The stock’s recent bullish momentum, attractive price-to-book ratio, and market-beating returns have contributed to this reassessment, signalling cautious optimism among investors.

Read full news article

Akums Drugs & Pharmaceuticals Ltd Shows Bullish Momentum Amid Technical Upgrades

2026-04-13 08:04:45

Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in price momentum, transitioning from a sideways trend to a bullish stance, supported by a series of positive technical indicator signals. This development comes alongside an upgrade in its MarketsMOJO grade from Sell to Hold, reflecting improved investor sentiment and technical strength in the small-cap pharmaceuticals sector.

Read full news article

Akums Drugs & Pharmaceuticals Ltd Gains 4.60%: 3 Key Technical Signals Driving the Week

2026-04-11 10:00:56

Key Events This Week

6 Apr: Week opens at Rs.492.85

7 Apr: Technical momentum shifts to mildly bearish amid mixed market signals

9 Apr: Momentum shifts to sideways trend with a 3.19% intraday gain

10 Apr: Golden Cross formation signals potential bullish breakout; stock closes at Rs.515.50 (+4.84%)

Week Open

Rs.492.85

Week Cl...

Read full news article

Golden Cross Forms in Akums Drugs & Pharmaceuticals Ltd — Mixed Technical Signals Demand Caution

2026-04-10 18:00:39

The 50-day moving average has crossed above the 200-day moving average for Akums Drugs & Pharmaceuticals Ltd, signalling a golden cross on 10 Apr 2026. Yet, the broader technical and fundamental picture presents a nuanced view that tempers the enthusiasm often associated with this crossover — is this a reliable signal or a misleading indicator for investors?

Read full news article

Akums Drugs & Pharmaceuticals Ltd is Rated Sell

2026-04-09 10:10:32

Akums Drugs & Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Akums Drugs & Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Signals

2026-04-09 08:07:07

Akums Drugs & Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent 3.19% gain in the stock price, the mixed signals from key technical indicators such as MACD, RSI, and moving averages suggest a cautious outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Akums Drugs & Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-07 08:06:11

Akums Drugs & Pharmaceuticals Ltd has experienced a subtle but notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish weekly indicators, the overall technical landscape presents a complex picture for investors, with mixed signals from key momentum and trend-following indicators.

Read full news article

View All News